blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2123258

EP2123258 - Liposomes for drug delivery [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  26.11.2010
Database last updated on 28.09.2024
Most recent event   Tooltip26.11.2010Application deemed to be withdrawnpublished on 29.12.2010  [2010/52]
Applicant(s)For all designated states
Liplasome Pharma A/S
Bygning 207, DTU Anker Engelundsvej 1
2800 Lyngby / DK
[2009/48]
Inventor(s)01 / Vikbjerg, Anders Falk
Vesthegnet 52
2670 Greve / DK
02 / Petersen, Sune Allan
Magevej 74, 3tv
2400 Copenhagen NV / DK
03 / Melander, Fredrik
Kristianstadgatan 35 A
21435 Malmö / SE
04 / Henriksen, Jonas Rosager
Gravenstensvej 14
3450 Allerod / DK
05 / Jorgensen, Kent
Bagsvaerd Hovedgade 99, 12H
2880 Bagsvaerd / DK
 [2009/48]
Representative(s)Christensen, Bent, et al
Chas. Hude A/S
H.C. Andersens Boulevard 33
1780 Copenhagen V / DK
[N/P]
Former [2009/48]Christensen, Bent, et al
Chas. Hude A/S H.C. Andersens Boulevard 33
1780 Copenhagen V / DK
Application number, filing date08014793.720.08.2008
[2009/48]
Priority number, dateDK2008000071723.05.2008         Original published format: DK 200800717
[2009/48]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2123258
Date:25.11.2009
Language:EN
[2009/48]
Search report(s)(Supplementary) European search report - dispatched on:EP23.01.2009
ClassificationIPC:A61K9/127, A61K33/24, A61K31/282
[2009/48]
CPC:
A61K9/1271 (EP,US); A61K33/243 (EP,US); A61K31/19 (EP,US);
A61K31/192 (EP,US); A61K31/203 (EP,US); A61K31/337 (EP,US);
A61K31/475 (EP,US); A61K31/513 (EP,US); A61K31/519 (EP,US);
A61K31/555 (EP,US); A61K31/704 (EP,US); A61K38/14 (EP,US);
A61P29/00 (EP); A61P31/00 (EP); A61P31/04 (EP);
A61P31/10 (EP); A61P35/00 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/36]
Former [2010/30](deleted) 
Former [2009/48]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Liposomen zur Arzneimittelverabreichung[2009/48]
English:Liposomes for drug delivery[2009/48]
French:Liposomes pour l'administration de médicaments[2009/48]
Examination procedure26.05.2010Application deemed to be withdrawn, date of legal effect  [2010/52]
12.08.2010Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2010/52]
31.12.2099Examination requested  [2010/39]
Fees paidPenalty fee
Additional fee for renewal fee
31.08.201003   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO9011781  (ALCON LAB INC [US]) [X] 1-5,8,11-32 * page 5, paragraph 4 * * page 6, paragraph 2 - page 7, paragraph 1 * * page 8; example 1 * * page 11; example 2 * * page 12 - page 13; example 3 * * claims 1-28 *;
 [X]WO9738010  (UNIV BRITISH COLUMBIA [CA], et al) [X] 1-11,13-22,28-30 * page 37, line 5 - page 39, line 3 * * page 40, lines 5-23 * * page 58, lines 18-27 * * page 66, lines 27-32 *;
 [X]US2003054027  (UNGER EVAN C [US]) [X] 1-11,13-17,20-22 * page 2, paragraphs 15-17 * * page 6, paragraphs 55,58 * * page 48; examples 1,2 * * page 49; example 6 *;
 [X]WO2004087105  (CELATOR TECHNOLOGIES INC [CA], et al) [X] 1-5,8-11,13-22,28-30 * page 4, paragraph 10 * * page 6, paragraphs 23,24 * * page 7, paragraphs 26,28-32 * * page 8, paragraphs 33,36 * * page 8, paragraph 38 - page 9, paragraph 41 * * page 20, paragraph 85 * * page 24, paragraph 99 * * page 27 - page 34; examples 2-6 *;
 [X]US2004203069  (REUTELINGSPERGER CHRIS [NL]) [X] 1-4,8,11,13-17,20-22,28-30 * page 3, paragraph 24 * * page 4; example 2 *;
 [X]WO2007028020  (NOVARTIS AG [CH], et al) [X] 28-32 * page 1, paragraph 4 - page 2, paragraph 3 * * page 8, paragraph L - page 9, paragraph L * * page 14, paragraph 6 * * page 17 - page 18; examples 1-4 *;
 [X]WO2007123691  (UNIV NEW YORK STATE RES FOUND [US], et al) [X] 28-32 * page 5, lines 27-32 * * page 7, line 26 - page 8, line 7 *;
 [A]US2008069778  (PARGAONKAR NIKHIL [US]) [A] 1-32 * page 2, paragraph 44 ** page 3; example 1 *;
 [X]  - STEFFAN G ET AL, "DIVALENT CATION-DEPENDENT INTERACTION OF SULFATED POLYSACCHARIDES WITH PHOSPHATIDYLCHOLINE AND MIXED PHOSPHATIDYLCHOLINE/PHOSPHATIDYLGLYCEROL LIPOSOMES", CHEMISTRY AND PHYSICS OF LIPIDS, LIMERICK, IR, (19940101), vol. 74, no. 2, ISSN 0009-3084, pages 141 - 150, XP002054990 [X] 1-3,8-17,22-32 * abstract * * page 142, column R, paragraph L - page 143, column L, paragraph 1 * * page 145, column R, paragraph L - page 146, column R, paragraph 2 * * page 146; figure 6 * * page 148, column R, paragraph L - page 149, column L, paragraph 1 *

DOI:   http://dx.doi.org/10.1016/0009-3084(94)90055-8
 [X]  - CHIU G N C ET AL, "Selective protein interactions with phosphatidylserine containing liposomes alter the steric stabilization properties of poly(ethylene glycol)", BIOCHIMICA ET BIOPHYSICA ACTA. BIOMEMBRANES, AMSTERDAM, NL, (20010209), vol. 1510, no. 1-2, ISSN 0005-2736, pages 56 - 69, XP004248767 [X] 28-30 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0005-2736(00)00335-7
by applicantEP1254143
 WO2006048017
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.